We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

BioLife Solutions Inc (BLFS) USD0.001

Sell:$14.60 Buy:$23.38 Change: $0.20 (0.92%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
Sell:$14.60
Buy:$23.38
Change: $0.20 (0.92%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
Sell:$14.60
Buy:$23.38
Change: $0.20 (0.92%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.

Contact details

Address:
SUITE 310, 3303 MONTE VILLA PARKWAY
BOTHELL
98021
United States
Telephone:
+1 (425) 4011400
Website:
https://www.biolifesolutions.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BLFS
ISIN:
US09062W2044
Market cap:
$1.00 billion
Shares in issue:
46.03 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Roderick De Greef
    Chairman of the Board, Chief Executive Officer, President
  • Troy Wichterman
    Chief Financial Officer
  • Aby Mathew
    Executive Vice President, Chief Scientific Officer
  • Geraint Phillips
    Senior Vice President - Global Operations
  • Todd Berard
    Chief Marketing Officer
  • Sarah Aebersold
    Vice President - Global Human Resources
  • Karen Foster
    Chief Quality Officer
  • Garrie Richardson
    Chief Revenue Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.